Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carolina Muguruza

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Frontiers in Pharmacology|June 1, 2016
Group II Metabotropic Glutamate Receptors as Targets for Novel Antipsychotic DrugsCarolina Muguruza, J Javier Meana, Luis F Callado
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 24, 2020
Cannabis and exercise: Effects of Δ<sup>9</sup>-tetrahydrocannabinol on preference and motivation for wheel-running in miceImane Hurel, Carolina Muguruza, Bastien Redon, et al.
European Journal of Medicinal Chemistry|June 9, 2014
Guanidine-based α2-adrenoceptor ligands: Towards selective antagonist activityDaniel H O'Donovan, Carolina Muguruza, Luis F Callado, et al.
Journal of Psychopharmacology (Oxford, England)|June 26, 2019
Endocannabinoid system imbalance in the postmortem prefrontal cortex of subjects with schizophreniaCarolina Muguruza, Benito Morentin, J Javier Meana, et al.
Schizophrenia Research|June 27, 2013
Quantification of endocannabinoids in postmortem brain of schizophrenic subjectsCarolina Muguruza, Marko Lehtonen, Niina Aaltonen, et al.
Neuropharmacology|September 18, 2012
Antidepressant-like properties of three new α2-adrenoceptor antagonistsCarolina Muguruza, Fernando Rodríguez, Isabel Rozas, et al.
Journal of Neuroscience Methods|January 20, 2025
A method for HDAC activity screening in postmortem human brain. A proof-of-concept study with antipsychoticsOihane Martínez-Peula, Alfredo Ramos-Miguel, Carolina Muguruza, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 27, 2012
Dysregulated 5-HT(2A) receptor binding in postmortem frontal cortex of schizophrenic subjectsCarolina Muguruza, José L Moreno, Adrienne Umali, et al.
European Journal of Medicinal Chemistry|June 24, 2017
Thiophene/thiazole-benzene replacement on guanidine derivatives targeting α<sub>2</sub>-AdrenoceptorsAoife Flood, Cristina Trujillo, Goar Sanchez-Sanz, et al.
Journal of Medicinal Chemistry|April 15, 2015
Correction to α₂-Adrenoceptor Antagonists: Synthesis, Pharmacological Evaluation, and Molecular Modeling Investigation of Pyridinoguanidine, Pyridino-2-aminoimidazoline and Their DerivativesBrendan Kelly, Michela McMullan, Carolina Muguruza, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Frontiers in Pharmacology|June 1, 2016
Group II Metabotropic Glutamate Receptors as Targets for Novel Antipsychotic DrugsCarolina Muguruza, J Javier Meana, Luis F Callado
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 24, 2020
Cannabis and exercise: Effects of Δ<sup>9</sup>-tetrahydrocannabinol on preference and motivation for wheel-running in miceImane Hurel, Carolina Muguruza, Bastien Redon, et al.
European Journal of Medicinal Chemistry|June 9, 2014
Guanidine-based α2-adrenoceptor ligands: Towards selective antagonist activityDaniel H O'Donovan, Carolina Muguruza, Luis F Callado, et al.
Journal of Psychopharmacology (Oxford, England)|June 26, 2019
Endocannabinoid system imbalance in the postmortem prefrontal cortex of subjects with schizophreniaCarolina Muguruza, Benito Morentin, J Javier Meana, et al.
Schizophrenia Research|June 27, 2013
Quantification of endocannabinoids in postmortem brain of schizophrenic subjectsCarolina Muguruza, Marko Lehtonen, Niina Aaltonen, et al.
Neuropharmacology|September 18, 2012
Antidepressant-like properties of three new α2-adrenoceptor antagonistsCarolina Muguruza, Fernando Rodríguez, Isabel Rozas, et al.
Journal of Neuroscience Methods|January 20, 2025
A method for HDAC activity screening in postmortem human brain. A proof-of-concept study with antipsychoticsOihane Martínez-Peula, Alfredo Ramos-Miguel, Carolina Muguruza, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 27, 2012
Dysregulated 5-HT(2A) receptor binding in postmortem frontal cortex of schizophrenic subjectsCarolina Muguruza, José L Moreno, Adrienne Umali, et al.
European Journal of Medicinal Chemistry|June 24, 2017
Thiophene/thiazole-benzene replacement on guanidine derivatives targeting α<sub>2</sub>-AdrenoceptorsAoife Flood, Cristina Trujillo, Goar Sanchez-Sanz, et al.
Journal of Medicinal Chemistry|April 15, 2015
Correction to α₂-Adrenoceptor Antagonists: Synthesis, Pharmacological Evaluation, and Molecular Modeling Investigation of Pyridinoguanidine, Pyridino-2-aminoimidazoline and Their DerivativesBrendan Kelly, Michela McMullan, Carolina Muguruza, et al.
Pageof 4